Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.
about
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@en
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@nl
type
label
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@en
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@nl
prefLabel
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@en
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@nl
P2093
P2860
P50
P921
P356
P1476
Cost-effectiveness of zofenopr ...... post hoc analysis of SMILE-4.
@en
P2093
Arrigo Fg Cicero
Claudio Borghi
Daniela Degli Esposti
Dragos Vinereanu
Ettore Ambrosioni
Giorgio Reggiardo
Giuseppe Ambrosio
Stefano Bacchelli
P2860
P304
P356
10.2147/CEOR.S43138
P407
P577
2013-07-08T00:00:00Z